Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDM25
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,843
Award facts
- Contract value 100% obligated
- $122,843.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $122,843.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a focused pharmaceutical procurement supporting federal healthcare needs. The award carries no set-aside designation, and performance will take place at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499.999 billion through November 2026. The parent contract authorizes the DLA to procure an extensive range of pharmaceutical products, including branded and generic medications, biologics, and medical consumables for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's role as the sole-source supplier under this significant IDC establishes the company as a critical partner in maintaining pharmaceutical supply chains for military medical operations, with this particular delivery order fulfilling an urgent requirement for the oncology treatment Keytruda.
Quick answers
Who was awarded contract SPE2DB25FDM25?
SPE2DB25FDM25 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FDM25 worth?
The government has obligated $122,843 on SPE2DB25FDM25.
Is contract SPE2DB25FDM25 an order under another contract?
Yes. SPE2DB25FDM25 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM25 competed?
The extent of competition for SPE2DB25FDM25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award